Objective: To assess the effect of antenatal diagnosis of Placenta Accreta Spectrum (PAS) on fetomaternal outcomes. Methods: This was a retrospective cohort study conducted from January 2017 to December 2018. Women whose PAS was diagnosed antenatally were included as (GROUP A) and those where diagnosis was suspected during operation and confirmed on histopathology were included as PAS diagnosed peroperatively (GROUP B). Outcome in terms of uterine conservation, maternal death, admission of mother to ICU and perinatal death and NICU admission were recorded. Results: During the study period, PAS was confirmed in 96 cases and were included. Out of these, 34 (35.4%) cases were antenatally diagnosed (group A) while 62 (64.6%) were diagnosed intraoperatively (Group B). Group A had lower median number of units of blood transfused as compared to group B (4 vs. 6, p˂0.001).Uterus was conserved in more cases (67.6% vs. 43.5%, p=0.024) of Group A and admission to ICU took place in (26.5% vs. 59.7%, p =0.002) more cases of GROUP B. Maternal death (p=0.038) and perinatal death (p=0.008) were also significantly higher in cases diagnosed intraoperatively (p=0.008). More neonates (85.7% vs. 24%, p=0.033) were admitted to ICU for cases diagnosed intraoperatively. Survival analysis showed a statistically significant difference in uterine conservation rate with antenatal diagnosis between the two groups (log rank, p value=0.04). Conclusions: PAS diagnosed antenatally has better fetomaternal outcomes than intraoperative detection of PAS. Diagnosing PAS antenatally is a key factor that influences management and results in better outcome. U n c o r r e c t e d P r o o f
INTRODUCTION:
Placenta accreta spectrum (PAS) is a well-known entity that has become far more common than previously reported (1) . This is partly dependent on the rising cesarean section rates in the region. But the effect of sophisticated techniques for diagnosing this condition is also noteworthy. PAS is associated with significant maternal morbidity and mortality. The condition when diagnosed antenatally allows mobilization of suitable resources and helps in curtailing the damage (2) . It was previously believed that the final diagnosis is confirmed retrospectively by histological examination of the specimen. This has been argued and studies have reported that novel techniques like power Doppler and magnetic resonance imaging have around 100% sensitivity in diagnosing these cases (3) . The actual problem arises when the cases are diagnosed intrapartum and the expertise though available at tertiary centers cannot be mobilized instantly (4) . Diagnosis of PAS has a lot to do with assessment of risk factors but that is not always the case and sometimes cases are missed especially in facilities with enormous patient load. In scenarios where an undiagnosed PAS is encountered the morbidity is presumed to multiply (5) . Despite the known fact that diagnosing PAS antenatally leads to decreased morbidity, the data remains sparse, as PAS is not frequently encountered, worldwide. Most evidence has been amalgamated from regions where antenatal care is optimal and cesarean sections are not that high (6, 7) . We are reporting this data from a region where antenatal care utilization is suboptimal and cesarean section rates are on an all-time high, and cases of PAS are seen more frequently. We undertook this study to assess the effect of antenatal diagnosis of PAS on morbidity seen in such cases.
PATIENTS AND METHODS:

U n c o r r e c t e d P r o o f
This was a retrospective cohort study conducted from 1 st January 2017 to 31 st December 2018. Consent for the use of hospital records was obtained from the department head. All labor room and obstetrics theatre records were analyzed to calculate the delivery rate at the hospital. The incidence of accreta was then calculated for the facility. All women who were diagnosed with placenta accreta spectrum on histopathology report were included in the analysis. Women whose histopathology was not sent and PAS was not confirmed were excluded. All cases were scrutinized for diagnosis; women who were diagnosed before they underwent anesthesia for cesarean delivery were included as antenatally diagnosed PAS (GROUP A). Cases where PAS was suspected during operation and confirmed on histopathology were included as PAS diagnosed peroperatively (GROUP B). For cases diagnosed antenatally, the surgery was performed by senior obstetrician, consultant anesthetist and consultant pediatrician was present for such cases. Four units of blood were arranged and continuous communication was maintained with the onsite blood bank. The patient's hemoglobin was regularly assessed antenatally and hemoglobin of above 11g/dl was maintained. All patients received antenatal steroids to promote lung maturation in fetus after 26 weeks. For this purpose injection betamethasone (Betnesol) was used in dose of 12 mgs. Patient was given two doses intramuscularly, 24 hours apart. The incision was given avoiding the placental location which was assessed preoperatively. The placental location was determined by an ultrasound assessment. Baby was delivered by going around the placenta and was handed over immediately to consultant pediatrician for ongoing neonatal care. A performa was used to collect data that included age of woman, her parity, duration of surgery in minutes and number of units of blood transfused. The primary outcome measure was uterine conservation. Secondary measures included maternal death, admission of mother to ICU and perinatal death and Neonatal intensive care unit admission. Duration of surgery in cases where uterus was conserved was also assessed. Data was coded and confidentiality was ensured. The hospital head gave permission to the investigators for reporting the study. In lieu of formal ethical approval, principles of Helsinki's declaration were followed. All data were entered and analyzed using SPSS version 15(SPSS Inc., Chicago, IL, USA). Shapiro Wilk's test was used to assess the normality of data. Women's age, parity, duration of surgery and number of units transfused were not normally distributed and were represented as median and range. Mann Whitney u test were used to compare the groups. Frequencies and percentages were calculated for qualitative variables uterine conservation, diagnosis antepartum/ intrapartum, ICU admission and neonatal death. Chi square test and Fischer's exact test were used to compare these variables at p< 0.05 level of significance. Time to uterine conservation was analyzed for both groups using Kaplan-Meier survival plots and curves were compared by means of mantel Haenszel log rank test. A significance level of 5% was chosen.
RESULTS:
During the study period, 8979 deliveries took place at the facility. PAS was confirmed in 96 of those women, giving an incidence of 0.0106% (1 in 100). Out of these, 34 (35.4%) cases were antenatally diagnosed (group A) while 62 (64.6%) were diagnosed intraoperatively (Group B). The median age of the study population was 28 years (range 21-35 years), median time of surgery was 55 minutes (50-140 minutes) and median units of blood transfused was 6 (2-12 units). Only 34 (35.4%) cases were diagnosed antepartum. Regarding risk factors, the median number of previous section in the study population was 1(range 0-4), only 16 (16.7%) had a history of dilation and curretage and 40(41.7%) gave history of bleeding. Uterus was conserved in 50 (52.1%) of women. ICU admission took place for 46(47.9%) of women and 23 (23.59%) women died. Regarding perinatal outcomes, perinatal mortality rate was 44.8%. Of these 31 (72.09%) were fresh stillbirths and 12 (27.91%) were neonatal deaths. Only 18(33.96%) neonates had Apgar score below 7 after 5 minutes and ICU admission of the baby took place for 30 (56.6%) of the neonates. Table  1 summarizes the characteristics of study population. When stratified according to groups, there was no significant difference in both groups with regards to age (p=0.865), parity (p=0.289) and duration of surgery (p=0.588). Both groups were also similar with respect to risk factors. The median number of cesarean sections (p=0.304), history of bleeding (p=0.703) and history of prior dilatation and curretage (p=0.427) was also similar in both groups. However, antenatally diagnosed PAS had lower median number of units of blood transfused as compared to intrapartum diagnosed PAS (4 vs. 6, p˂0.001). Uterus was conserved in 23 (67.6%) cases of GROUP A and 27 (43.5%) cases of GOUP B (p=0.024). Admission to ICU took place in 9(26.5%) cases of GROUP A and 37(59.7 %) cases of GROUP B (p=0.002). Maternal death (p=0.038) and perinatal death (p=0.008) were also significantly higher in cases diagnosed peroperatively (p=0.008). More neonates (85.7% vs. 24%, p=0.033) were admitted to ICU for cases diagnosed intraoperatively. Table 2 Survival analysis showed a statistically significant difference in duration of surgery with antenatal diagnosis between the two groups (log rank, p value=0.04). The present study shows the effect of antenatal diagnosis of PAS on fetomaternal outcomes. Our study shows that outcomes are better in cases of placenta accreta spectrum where diagnosis is made antenatally. Women need less units of blood transfusion when diagnosed antenatally and are more likely to retain their uterus. Duration of surgery is also lower in such cases. Also admission of mother to ICU occurs less frequently and perinatal deaths are also lower in diagnosed cases of PAS.
Strength and limitation:
As placenta accreta is seen frequently due to higher cesarean rates in the setup, the strength of this study is its sample size. Another big strength of the study is the definition used to specify PAS. All cases that were included were histologically confirmed. This removes subjective bias of labeling a case as PAS. Major limitation is the retrospective design. As cases were assessed retrospectively patient reported outcomes could not be assessed.
Interpretation:
Rates of placenta accreta have sky rocketed in the recent times. Placenta accreta was previously seen occasionally. In the developed countries the rates are lower than the ones seen in developing world. The estimated incidence from the UK was 1.7 per 10000 maternities (8) while that from Australia was 44.2/100000 women giving birth (9) . The prevalence varied from 0.01% to 1.1% according to a large database review (10) . These rates are alarming as the cesarean rates are also on the rise and this could potentially mean more cases would be encountered in the near future. The rate in our study was 0.010% which is very high in comparison to the data previously reported. Another reason for this rate could be the fact that the facility is a tertiary care center and deals with all high risk cases that are referred from all parts of the city. Increased maternal age, previous cesarean section and increased parity are among commonly recognized risk factors for PAS (11) . The median age of the study population was 28 years (range 21-35 years) and they had a median parity of 2(1-5) which shows that the women were below the advanced maternal age range and might have not completed their families . The median maternal age reported for placenta accreta is around 34 years and the median parity is 2.5 (12) . This by extension could mean that placenta accreta may soon start claiming uteri of such younger women, as PAS in the most commonly reported indication of peripartum hysterectomy. Diagnosis of PAS antenatally can substantially reduce morbidity. Only 34 (35.4%) cases were diagnosed antepartum, this is lower than the cases diagnosed antenatally in the study reported from Australia where 57% of the cases were antenatally diagnosed. In that study, 36% of the cases were diagnosed solely on ultrasound. [9] Our hospital records showed that all cases of PAS that were antenatally diagnose, were suspected on grey scale ultrasound and confirmed on color Doppler. 3-D power Doppler has been shown to have the best prediction of antenatal PAS (13) . Since the facility was not available at the center our cases were diagnosed on color Doppler. Availability of senior colleagues or experts has been shown to improve outcome in difficult and complex cases (14) . Multidisciplinary team involvement and specialized centers for managing PAS have been reporting better outcomes for PAS. But these sources can only be mobilized in antenatally diagnosed patients. In cases where accreta is diagnosed on operating table, such expertise is difficult to arrange instantaneously (15) . Our study highlights the importance of preparedness for such emergencies as antenatally diagnosed cases had improved outcome. The duration of surgery is an important morbidity marker. Women with prolonged surgeries are more likely to be shifted to ICU, have a longer duration of stay at hospital, and suffer wound infections and other postoperative complications (16) . Duration of surgery was not significantly different between groups but women who had PAS diagnosed antenatally had lower requirement of blood transfusion. Also, in cases where uterus was conserved, time to uterine conservation was also less. This finding may be explained by the fact that these cases were optimized antenatally, hemoglobin was kept in check and operation was done by experts under favorable conditions. The planning and anticipation of complications in cases of PAS is associated with improved outcomes overall (17) . Fetomaternal outcomes were also influenced by the timing of diagnosis in the study. Only 9(26.5%) cases of GROUP A as compared to 37(59.7 %) cases of GROUP B (p=0.002) were admitted to ICU. Perinatal death was also significantly higher in cases diagnosed intrapartum (p=0.008). These findings are in agreement with the studies reported previously (18, 19) . Our study shows the beneficial effect of diagnosing PAS antenatally. This diagnosis becomes even more important in regions where antenatal care remains suboptimal because these women have far worse fetomaternal outcomes than women who receive better care. The importance of a scan to localize placenta antenatally in all women and confirm invasion especially in cases with a previous scar cannot be emphasized enough. Just diagnosing PAS is not sufficient, dedicated centers for PAS are need of the hour. Women in our study though delivering at a tertiary care did not achieve as good an outcome as reported by studies from the developed world.
U n c o r r e c t e d P r o o f
If PAS is diagnosed antenatally, women are counseled and optimized prior to delivery and delivery takes place at a dedicated center with sufficient expertise, much better outcomes can be expected. Development of dedicated PAS centers in the developing countries can be expected to make a huge difference. After establishment of such centers, a larger study with prospective design can help assess the outcomes in true sense of antenatal diagnosis in such cases. PAS diagnosed antenatally has better fetomaternal outcomes than intraoperative detection of PAS. Diagnosing PAS antenatally is a key factor that influences management and results in better outcome. We propose adoption of antenatal localization of placenta in all cases, especially where risk factors for PAS are present. 
